Form 4 for BIIB Biogen
Accepted 2024-12-09 00:00:00 ET · period of report 2024-12-06 · accession 0001127602-24-028860 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-09 | 2024-12-06 | BIIB | Kramer Robin | CAO | F - Tax | $157.78 | -170 | 6,408 | -3% | -$26.8K |
| D | 2024-12-09 | 2024-12-06 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | +351 | 6,578 | +6% | $0 |
| D | 2024-12-09 | 2024-12-06 | BIIB | Kramer Robin | CAO | M - OptEx | $0.00 | -351 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-06 | F | D | 170 | $157.78 | 6,407.75 | D | — | — | |
| 2 | Common | Common Stock | 2024-12-06 | M | A | 351 | $0.00 | 6,577.75 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2024-12-06 | M | D | 351 | $0.00 | 0 | D | $0.00 · — to 2024-12-08 | 351 Common Stock | (F1) The restricted stock units vest in three (3) equal annual installments commencing on the first anniversary of the grant date of 12/8/2021. |